Study of Anastrozole, Letrozole, or Exemestane With or Without Tamoxifen in Treating Postmenopausal Women With Hormone-Responsive Breast Cancer That Has Been Completely Removed By Surgery
This study is currently recruiting participants.
Verified October 2007 by National Cancer Institute (NCI)
Sponsor:
Gruppo Italiano Mammella (GIM)
Information provided by:
National Cancer Institute (NCI)
ClinicalTrials.gov Identifier:
NCT00541086
First received: October 5, 2007
Last updated: November 10, 2010
Last verified: October 2007
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | No date given |
| Estimated Primary Completion Date: | March 2016 (Final data collection date for primary outcome measure) |